Nitrosative Stress and Apoptosis by Intravenous Ferumoxytol, Iron Isomaltoside 1000, Iron Dextran, Iron Sucrose, and Ferric Carboxymaltose in a Nonclinical Model

Drug Research

Volumn 65, Issue 7, 2014, Pages 354-360

  Toblli, J E ^a   Cao, G ^a   Giani, J F ^b   Dominici, F P ^b   Angerosa, M ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Instituto de Quimica y Fisicoquimica Biologicas Buenos Aires   (Argentina)

Author keywords

caspase 3; nitrotyrosine; rat

Indexed keywords

3 NITROTYROSINE; ANTIANEMIC AGENT; CASPASE 3; FERRIC CARBOXYMALTOSE; FERUMOXYTOL; IRON DEXTRAN; IRON ISOMALTOSIDE 1000; IRON SACCHARATE; UNCLASSIFIED DRUG; 3-NITROTYROSINE; DISACCHARIDE; FERRIC ION; FERRIC OXIDE, SACCHARATED; MAGNETITE; MALTOSE; SACCHARIC ACID; TYROSINE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; HEART; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; KIDNEY; KIDNEY TUBULE CELL; LEYDIG CELL; LIVER; LIVER CELL; MALE; NITROSATIVE STRESS; NONHUMAN; PODOCYTE; PROTEIN EXPRESSION; RAT; TISSUE HOMOGENATE; TISSUE SECTION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; ANIMAL MODEL; BIOSYNTHESIS; CARDIAC MUSCLE; DRUG EFFECTS; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM;

ADMINISTRATION, INTRAVENOUS; ANIMALS; APOPTOSIS; CASPASE 3; DISACCHARIDES; FEMALE; FERRIC COMPOUNDS; FERROSOFERRIC OXIDE; GLUCARIC ACID; IRON-DEXTRAN COMPLEX; KIDNEY; LIVER; MALE; MALTOSE; MODELS, ANIMAL; MYOCARDIUM; RATS; TYROSINE;

EID: 84937023535     PISSN: 21949379     EISSN: 21949387     Source Type: Journal    
DOI: 10.1055/s-0034-1384534     Document Type: Article

References (34)

1. Stamler J. S., Singel D. J., Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science: 1992; 258 1898 1902
2. Forstermann U., Li H., Schwarz P. M. et al. NO synthesis and NOS regulation. In: Forman H. J., Fukuto J. M., Torres M. (eds.) Signal transduction by reactive oxygen and nitrogen species: Pathways and chemical principles. Dordrecht Kluwer Academic Publishers: 2003; 119 154
3. Hill B. G., Dranka B. P., Bailey S. M. et al. What part of NO don't you understand? Some answers to the cardinal questions in nitric oxide biology. J Biol Chem: 2010; 285 19699 19704
4. Koskenkorva-Frank T. S., Weiss G., Koppenol W. H. et al. The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: Insights into the potential of various iron therapies to induce oxidative and nitrosative stress. Free Radic Biol Med: 2013; 65C 1174 1194
5. Stamler J. S. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell: 1994; 78 931 936
6. Pacher P., Beckman J. S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev: 2007; 87 315 424
7. Kim K. M., Kim P. K., Kwon Y. G. et al. Regulation of apoptosis by nitrosative stress. J Biochem Mol Biol: 2002; 35 127 133
8. Virg L., Szabó É, Gergely P. et al. Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. Toxicol Lett: 2003; 140-141 113 124
9. Toblli J. E., Cao G., Oliveri L. et al. Evaluation of toxicity and oxidative stress induced by intravenous iron isomaltoside 1000 in a nonclinical model. Drug Res: 2011; 61 553 565
10. Toblli J. E., Cao G., Oliveri L. et al. Assessment of the extent of oxidative stress induced by intravenous ferumoxytol, ferric carboxymaltose, iron sucrose and iron dextran in a nonclinical model. Drug Res: 2011; 61 399 410
11. Giani J. F., Gironacci M. M., Muñoz M. C. et al. Angiotensin-(1-7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors. Am J Physiol Heart Circ Physiol: 2007; 293 H1154 H1163
12. Muñoz M. C., Argentino D. P., Dominici F. P. et al. Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats. J Hypertens: 2006; 24 1607 1617
13. Toblli J. E., Cao G., Olivieri L. et al. Comparison of the renal, cardiovascular and hepatic toxicity data of original intravenous iron compounds. Nephrol Dial Transplant: 2010; 25 3631 3640
14. Cornejo P., Tapia G., Puntarulo S. et al. Iron-induced changes in nitric oxide and superoxide radical generation in rat liver after lindane or thyroid hormone treatment. Toxicol Lett: 2001; 119 87 93
15. Lu N., Li X., Li J. et al. Nitrative and oxidative modifications of enolase are associated with iron in iron-overload rats and in vitro. J Biol Inorg Chem: 2011; 16 481 490
16. Zhou X. J., Laszik Z., Wang X. Q. et al. Association of renal injury with increased oxygen free radical activity and altered nitric oxide metabolism in chronic experimental hemosiderosis. Lab Invest: 2000; 80 1905 1914
17. Bailie G. R., Schuler C., Leggett R. E. et al. Oxidative effect of several intravenous iron complexes in the rat. Biometals: 2013; 26 473 478
18. Bouton C., Hirling H., Drapier J. C. Redox modulation of iron regulatory proteins by peroxynitrite. J Biol Chem: 1997; 272 19969 19975
19. Galleano M., Simontacchi M., Puntarulo S. Nitric oxide and iron: effect of iron overload on nitric oxide production in endotoxemia. Mol Aspects Med: 2004; 25 141 154
20. Barbouti A., Amorgianiotis C., Kolettas E. et al. Hydrogen peroxide inhibits caspase-dependent apoptosis by inactivating procaspase-9 in an iron-dependent manner. Free Radic Biol Med: 2007; 43 1377 1387
21. Kim Y. M., Chung H. T., Simmons R. L. et al. Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition. J Biol Chem: 2000; 275 10954 10961
22. Sliskovic I., Mutus B. Reversible inhibition of caspase-3 activity by iron(III): potential role in physiological control of apoptosis. FEBS Lett: 2006; 580 2233 2237
23. Brunk U. T., Neuzil J., Eaton J. W. Lysosomal involvement in apoptosis. Redox Rep: 2001; 6 91 97
24. Henderson P. A., Hillman R. S. Characteristics of iron dextran utilization in man. Blood: 1969; 34 357 375
25. Danielson B. G. Structure, chemistry, and pharmacokinetics of intravenous iron agents. J Am Soc Nephrol: 2004; 15 02 S93 S98
26. Olsson K. S., Weinfeld A. Availability of iron dextran for hemoglobin synthesis as studied with phlebotomy. Acta Med Scand: 1972; 192 543 549
27. Kurz T., Terman A., Gustafsson B. et al. Lysosomes in iron metabolism, ageing and apoptosis. Histochem Cell Biol: 2008; 129 389 406
28. Kurz T., Eaton J. W., Brunk U. T. The role of lysosomes in iron metabolism and recycling. Int J Biochem Cell Biol: 2011; 43 1686 1697
29. Ding W. X., Yin X. M. Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury. J Cell Mol Med: 2004; 8 445 454
30. Shiratori Y., Ohmura K., Hikiba Y. et al. Hepatocyte nitric oxide production is induced by Kupffer cells. Dig Dis Sci: 1998; 43 1737 1745
31. Kim Y. M., Kim T. H., Chung H. T. et al. Nitric oxide prevents tumor necrosis factor alpha-induced rat hepatocyte apoptosis by the interruption of mitochondrial apoptotic signaling through S-nitrosylation of caspase-8. Hepatology: 2000; 32 770 778
32. Jahn M. R., Andreasen H. B., Fütterer S. et al. A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer®), a new intravenous iron preparation and its clinical implications. Eur J Pharm Biopharm: 2011; 78 480 491
33. Stern S. T., Adiseshaiah P. P., Crist R. M. Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity. Part Fibre Toxicol: 2012; 9 20
34. Stern S. T., Johnson D. N. Role for nanomaterial-autophagy interaction in neurodegenerative disease. Autophagy: 2008; 4 1097 1100.